Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats
2005 · British Journal of Cancer · 419 citations
https://doi.org/10.1038/sj.bjc.6602772
F
Fumiaki Koizumi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
213
Papers
4.7K
Citations
38
h-index
69
i10-index
Fumiaki Koizumi is an academic researcher from Tokyo Metropolitan Komagome Hospital. The author has contributed to research in topics: Cancer Cells and Metastasis & HER2/EGFR in Cancer Research & Lung Cancer Treatments and Mutations. The author has an h-index of 38, co-authored 182 publications.
Papers by this author
worksFcγR2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer
2010 · Annals of Oncology · 181 citations
https://doi.org/10.1093/annonc/mdq585
Efficacy of everolimus, a novel m<scp>TOR</scp> inhibitor, against basal‐like triple‐negative breast cancer cells
2012 · Cancer Science · 95 citations
https://doi.org/10.1111/j.1349-7006.2012.02359.x
NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel
2006 · British Journal of Cancer · 89 citations
https://doi.org/10.1038/sj.bjc.6603311
Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma
2013 · British Journal of Cancer · 84 citations
https://doi.org/10.1038/bjc.2013.348
Activated PI3K/AKT and MAPK pathways are potential good prognostic markers in node-positive, triple-negative breast cancer
2014 · Annals of Oncology · 59 citations
https://doi.org/10.1093/annonc/mdu247
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat